with a prevalence of 10% lameness reported by farmers who treat lame sheep bytrimming 19 affected feet. We tested the hypothesis that prompt treatment of sheep lame with naturally 20 developing FR or ID with parenteral and topical antibacterials reduces the prevalence and 21 incidence of lameness with these conditions compared with less frequent treatment by trimming 22 hoof horn and applying topical antibacterials. A further hypothesis was that reduction of ID and 23 FR would improve productivity. A lowland sheep flock with 700 ewes was used to test these 24 hypotheses in an 18-month within farm clinical trial with four groups of ewes: two intervention 25 and two control. The duration and severity of lameness was used to categorise sheep into three 26 weighted scores of lameness (WLS): never lame (WLS0), lame for a maximum of six days with 27 locomotion score 2 (WLS1) and lame for more than six days or a higher locomotion score 28 (WLS2). The intervention reduced the prevalence of lameness due to FR and ID in ewes and 29 lambs and the incidence of lameness in ewes. The WLS was significantly lower in sheep in the 30 intervention groups. Ewes with a higher WLS were subsequently significantly more likely to 31 have a body condition score (BCS) <2.5 and have lame lambs. Significantly more ewes lambed 32 and successfully reared more lambs that were ready for slaughter at a younger age in the 33 intervention versus control groups. There was an increase in the gross margin of £630 / 100 ewes 34 mated in the intervention group, including the cost of treatment of £150 / 100 ewes mated. We 35 conclude that prompt parenteral and topical antibacterial treatment of sheep lame with ID and FR 36 reduced the prevalence and incidence of these infectious conditions and led to improved health, 37 welfare and productivity. 38 -3 - Lameness is one of the greatest concerns for poor welfare in sheep (Goddard et al., 2006; 44 Fitzpatrick et al., 2006). It has been estimated to cost the UK industry £24 million / annum 45 (Nieuwhof and Bishop, 2005). More than 90% of farmers in the UK report lameness in their 46 sheep, with a farmer-estimated prevalence of 10% with more than 80% of lameness caused by 47 footrot (FR) and interdigital dermatitis (ID) (Grogono-Thomas and Johnston, 1997; Kaler and 48 Green, 2008a). In a study of 209 sheep farmers, those treating all sheep with FR with parenteral 49 antibacterials and foot sprays reported a significantly lower peak prevalence of FR of 2% 50 compared with the 9%reported by farmers who treated FR by paring the hoof horn and spraying 51 disinfectant on to the foot (Wassink et al., 2003) . In addition, farmers who reported prompt 52 treatment of mildly lame sheep also reported a lower prevalence of lameness than those treating 53 groups of lame sheep (Kaler and Green, 2008). Further evidence for the benefits of parenteral 54 antibiotics comes from a prospective longitudinal study of 160 sheep on one farm where the 55 treatment of sheep with FR and ID with parenteral and topical antibacterials was associated with 56 a lower incidence of lameness in the subsequent 4 weeks (Green et al., 2007). 57
hoof horn and applying topical antibacterials. A further hypothesis was that reduction of ID and 23 FR would improve productivity. A lowland sheep flock with 700 ewes was used to test these 24 hypotheses in an 18-month within farm clinical trial with four groups of ewes: two intervention 25 and two control. The duration and severity of lameness was used to categorise sheep into three 26 weighted scores of lameness (WLS): never lame (WLS0), lame for a maximum of six days with 27 locomotion score 2 (WLS1) and lame for more than six days or a higher locomotion score 28 (WLS2). The intervention reduced the prevalence of lameness due to FR and ID in ewes and 29 lambs and the incidence of lameness in ewes. The WLS was significantly lower in sheep in the 30 intervention groups. Ewes with a higher WLS were subsequently significantly more likely to 31 have a body condition score (BCS) <2.5 and have lame lambs. Significantly more ewes lambed 32 -7 - (Table 1) were culled from all four groups and replacement ewes were added to the groups to 129 balance the number of sheep per group. Both replacement ewes and rams used for mating were 130 examined and if necessary treated. These sheep were not put with their group until sound. large straw-bedded solid-floored pens until they lambed. Straw was added to the pens each day 137 and was 30 -40 cm deep. Ewes were moved to individual pens after they had lambed. 138 139
Study design from May to September 2006 140
Two intervention groups and two control groups were re-formed from the merged intervention 141 group and merged control group, respectively (Table 2) . No ewes were put out to pasture until 142 sound. Treatments for lameness started when the youngest lamb in a group was four weeks old. 143
The intervention and control groups were treated as for the first lamb production season (2005) condition was categorised into below recommended (<2.5) and at or above recommended (≥2.5), 157 birth weights were categorised by a good vs less good birth weight of <5.5kg and ≥ 5.5 kg and 158 ewe age at a median of <4 years and ≥ 4 years. Breed was categorised into mule and other cross-159 breeds. Parametric and non-parametric tests were used to investigate univariable associations as 160 appropriate for the data distributions. The groups compared were intervention and control groups in 2005 and 2006 and also the sub 166 group of ewes that were always in an intervention group or always in a control group (n = 176). 167
These ewes were dispersed within the two intervention and two control groups in 2006. 168
169
The mean prevalence and incidence of lameness were plotted to visualise the effects of the 170 intervention and the cross-over design. The prevalence and incidence of lameness in matched 171 groups were compared using t tests. The prevalence was calculated from the number of sheep 172 with locomotion score 2 or above at an observation divided by the number of sheep in the group-9 -divided by the number of days that observations occurred in a period. The incidence was 174 calculated in the same way except that the denominator was the group size minus the number of 175 non-susceptible sheep (those lame within the last 10 days). 176
Sheep had up to four episodes of lameness in a time period. To test the hypothesis that duration 177 and severity of lameness affected production an weighted lameness score (WLS) was calculated 178 where d = duration of an episode of lameness, m = maximum locomotion score during the 179 episode of lameness, Σ = summed for all episodes of lameness in a time period 180
an episode of lameness started on the day the locomotion score was first observed ≥2 and ended 182 on the day midway between the last observation of locomotion score ≥2 and next observation of 183 locomotion score <2, unless a sheep was observed lame again within 10 days in which case this 184 was part of the current episode. 185
The WLS was then categorised into WLS0, sheep that never had a locomotion score ≥2, WLS1, 186
sheep with a weighted lameness score ≤12 (e.g. a sheep lame over 2 episodes, one with 3 days of 187 locomotion score 2 and another with 2 days of locomotion score 3) and WLS2, sheep with a 188 weighted lameness score >12. This three level categorical variable was used in an ordinal 189 multilevel multinomial regression analysis (Goldstein, 2003) Table 1 ) but there was no significant difference in the mean 214 incidence of lameness.
Over the intervention period, 35 isolates of D. nodosus cultured from ewes treated with 216 parenteral antibacterials at least twice were tested for antibacterial resistance to oxytetracycline 217 using a modified MIC test. All isolates were sensitive to oxytetracycline (DEFRA, 2008) . 218 219
Factors associated with lameness 220
The intervention treatment significantly reduced the number and / or severity of lameness events: 221 ewes and lambs in the control groups were more likely to have a WLS2 than ewes and lambs in 222 the intervention groups (Table 1) . WLS2 was also more likely in ewes > 4 yrs old (Table 5) and 223 in lambs which were single born, male or their mother was lame, especially if the ewe had had a 224 WLS2 (Table 5) likely to become lame in this period if she had been lame in the previous lamb production period 227 (Table 1) . 228 Cost-benefit analysis of the intervention 240
The cost of reducing the prevalence of lameness in the first six weeks of the study in 2005 was 241 £45 and £278 per 100 ewes in the two intervention groups; the prevalence of lameness fell more 242 rapidly in one intervention group than the other (Figure 1) . 243
There were 167 ewes that were either in intervention or control groups for the whole project. 244
From week 8 until the end of the project the mean prevalence and incidence of lameness in ewes 245 that were always in intervention groups (solid black line, Figure 1 ) were significantly lower than 246 in ewes that were always in control groups (dashed black line, Figure 1 ) (2.4 (95% CI: 1.7 -3.1) 247 vs. 5.6 (CI: 4.6 -6.6) and 1.4 (CI: 1.0 -1.8) vs. 2.5 (CI: 1.9 -3.1), respectively). These ewes 248 were used to estimate the impact of the intervention on productivity because they remained under 249 the same treatment for two seasons. 250
There were fewer barren ewes and ewes that died among ewes always in the intervention group 251 than always in the control group, resulting in more productive ewes per 100 ewes put to the ram 252 and lower replacement costs (Table 9 ). There were 17 more lambs reared per 100 ewes put to the 253 ram. In 2006, one year after the intervention was started, a significantly higher percentage of 254 lambs born to ewes always in the intervention group were finished before weaning compared 255 with lambs born to ewes in the control group; 18% versus 6%, respectively ( Table 8 ).
The additional cost of the intervention was calculated as £150 per 100 ewes put to the ram (Table  257 4). The intervention improved the gross margin by £630 in 2006 (Table 9) Significantly more lambs were finished before weaning in the intervention groups than in the 297 control groups. This is a very important component of the cost effectiveness of the treatment 298 because one of the main factors determining profitability of lowland flocks is the percentage of 299 lambs finished (MLC, 2001 ). This is because supplementary feed to lambs after weaning is 300 expensive and so impacts on profits. This, together with the production benefits from the currentintervention ( In this trial there was no evidence that the parenteral treatments led to bacterial selection for 309 resistance to oxytetracycline. This might be because although there were many treatments they 310
were staggered over time with 1 -8 treatments per group per week, so there was no selective 311 pressure for development of resistance. Whilst the use of parenteral antibiotic to treat infectious 312 lameness might not be considered the ideal, it is highly efficacious as a treatment and, as this 313 trial has clearly shown, of considerable benefit to animal welfare and production. It is the best 314 current treatments, the alternatives, trimming and spraying individuals and the whole flock 
Study design 320
This within farm clinical trial testing two treatments was carried out on one lowland spring-321 lambing flock with a compliant farm management team. This approach enabled us to make 322 detailed observations and collect a comprehensive, reliable dataset. We are uncertain whether the 323 improvements that occurred through the intervention would be quantitatively similar on otherlowland sheep farms with similar management and prevalence of FR and ID in the UK and 325
worldwide, but we would expect the qualitative results to be generalisable. The distribution of 326 age, BCS, foot conformation (Hawker, 2007) and prevalence of lameness in ewes at the start of 327 the study were similar in all four groups, suggesting that the random stratification was successful. 328
The prevalence of lameness (8%) was also similar to that reported by farmers in previous studies 329 
